Herbert Smith Freehills advised CICC and CSCI on the deal while O’Melveny recently represented 3D Medicines. CICC and CSCI acted as joint sponsors of 3D Medicines...
3D Medicines Inc.’s Listing on the Stock Exchange of Hong Kong
Gaush Meditech Limited’s HK$672 Million IPO
Harneys and Tianyuan acted as Cayman Islands counsel to Gaush Meditech Limited, Tian Yuan Law Firm LLP, O’Melveny & Myers and Commerce & Finance Law Offices...
Jenscare Scientific’s Hong Kong IPO
O’Melveny represented Jenscare Scientific Co., Ltd on the deal. Herbert Smith Freehills advised China International Capital Corporation and Citigroup. Jenscare Scientific Co., Ltd. (9877.HK) announced its...
Rainmed Medical’s HK$146 Million IPO and Listing on the Hong Kong Stock Exchange
O’Melveny and Grandall represented Rainmed Medical Limited (2297.HK) on the deal. Herbert Smith Freehills has advised Huatai Financial Holdings. Rainmed Medical Limited (2297.HK) announced its US$19...
Lushang Life Services Co., Ltd.’s HK$138.4 Million Hong Kong IPO
Sidley represented Lushang Life Services Co., Ltd. on the deal while O’Melveny advised ABCI Capital Limited and China International Capital Corporation Hong Kong Securities Limited. Lushang...
Bio-heart Biological Technology Co. Ltd.’s Listing on the Stock Exchange of Hong Kong
Herbert Smith Freehills has advised Huatai Financial Holdings (Hong Kong) Limited. O’Melveny & Myers represented Bio-heart on the deal. Huatai Financial Holdings (Hong Kong) Limited acted...
Yonghe Medical Group Co.’s US$192 Million Hong Kong IPO
O’Melveny & Myers LLP advised Yonghe Medical on the deal. Yonghe Medical Group Co., Ltd. (2279.HK) announced its HK$1.49 billion (approximately US$192 million) initial public offering and...
Gushengtang Holding Limited’s HK808.5 Million IPO
Harneys, Tian Yuan Law Firm LLC, and O’Melveny & Myers LLP acted for Gushengtang Holding Limited. Linklaters and Zhong Lun Law Firm assisted the joint sponsors....
Acotec Scientific Holdings Limited’s HK$1.529 Billion Hong Kong Initial Public Offering
Herbert Smith Freehills has advised Morgan Stanley and CICC on the matter while O’Melveny & Myers and Maples and Calder represented Acotec Scientific Holdings Limited. The...
Keymed Biosciences’ US$400 Million Hong Kong IPO
O’Melveny & Myers and Cooley LLP advised Keymed Biosciences Inc. on the deal, while Kirkland & Ellis advised the joint sponsors and underwriters. Keymed Biosciences Inc....
Peijia Medical Limited’s Listing On The Hong Kong
Herbert Smith Freehills has advised Morgan Stanley Asia Limited and Huatai Financial Holdings as joint sponsors. O’Melveny & Myers LLP and and Jingtian & Gongcheng advised...